Diabetes, Obesity & Metabolism

Absence of Interaction Between 5α-Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes

By Haolan Tu, Chengsheng Ju, Stuart J. McGurnaghan, Ruth Andrew

Study in peoplePopulations

The paper

Haolan Tu, Chengsheng Ju, Stuart J. McGurnaghan, Ruth Andrew

University of Edinburgh

Diabetes, Obesity & Metabolism, 3 Aug 2026

doi.org/10.1111/dom.71148 PubMed 42547757

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs